Fosamax linked to Osteonecrosis (fossy jaw)

Merck’s osteoporosis drug Fosamax has been named in a lawsuit filed by a woman suffering from osteonecrosis of the jaw, a rare but debilitating and disfiguring condition in which soft tissue in the jawbone dies from infection. It is an irreversible condition. Unfortunately, simply halting Fosamax therapy may not limit your risk if you’ve been taking Fosamax. If you’ve experienced dental pain, “heavy jaw feeling,” or swelling in the jaw and take Fosamax, you may want to consult with a lawyer to protect your rights. For more information …